BCL9L and neoplasm: The mRNA and protein levels of the IFN-γ-induced chemokine CXCL9 were also upregulated in tumors from hsBCL9z96-treated CT26 tumor-bearing mice and MC38 tumor-bearing Bcl9/Bcl9l deficiency mice (Fig. 7d, e).